Experts discuss the use of BRAF and MEK inhibitors as first-line treatments for patients with metastatic melanoma.
Video Reports
Dr. Eroglu on the Utilization of ctDNA in Melanoma
Zeynep Eroglu, MD, medical oncologist, Department of Cutaneous Oncology, Moffitt Cancer Center, assistant professor, Department of Oncologic Sciences, the University of South Florida, Morsani College of Medicine, discusses the utilization of circulating tumor DNA (ctDNA) in patients with melanoma.
New Long-term Data ‘Clearly Favor’ Combination Ipilimumab/Nivolumab in Melanoma
Dr Jeffrey Weber discusses long-term follow-up data presented at ASCO 2021.
Dr. Hamid on the Efficacy of TILs Following Immunotherapy in Advanced Melanoma
Omid Hamid, MD, discusses the efficacy of tumor-infiltrating lymphocyte therapy following immunotherapy in advanced melanoma.